Chester County News and Community Website
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has been awarded a Group Purchasing Agreement with Premier …
Read More MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that the Centers for Medicare and Medicaid Services (CMS) established a …
Read More MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced a virtual poster presentation highlighting new Phase IIIb ANJESO® (meloxicam) injection …
Read More MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that it has entered into a Pharmacy Supplier Agreement with Vizient, …
Read More MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced a virtual poster presentation highlighting ANJESO™ (meloxicam) injection data at Digestive …
Read More MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced two virtual poster presentations highlighting new ANJESO™ (meloxicam) injection data at …
Read More
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced that ANJESO™ (meloxicam) injection, the only 24-hour, intravenous (IV) COX-2 preferential …
Read More